Major players in the Therapeutic Drug Monitoring Market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, white papers, medical journals, certified publications, articles from recognized authors, directories, databases such as WHO, OECD, American Association for Clinical Chemistry (AACC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Trade Association, NCBI, and National Health Service (NHS).
The Global Therapeutic Drug Monitoring Market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9%
According to the new market research report "Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023", published by MarketsandMarkets™.
The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443
Therapeutic Drug Monitoring Market Segmentation:
On the basis of product, the global market is segmented into consumables and equipment. The consumables segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the requirement of repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
On the basis of technology, the global market is segmented into immunoassays and chromatography-MS. The immunoassays segment is expected to account for the largest share of this market in 2018, mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.
Asia Pacific is expected to grow at the highest CAGR during the forecast period
The APAC market is projected to register the highest growth during the forecast period. Growth in this region can be attributed to the huge demand for better healthcare services; increasing incidence of chronic and infectious diseases; rapid development in healthcare infrastructure in developing countries such as India, China, and South Korea; growing healthcare research investments in this region; and increasing per capita income of the middle-class population.
Read a Press-Release on “Therapeutic Drug Monitoring Market”:
https://www.marketsandmarkets.com/PressReleases/therapeutic-drug-monitoring.asp
Major Leading Key Players in the Therapeutic Drug Monitoring Market -
The key players operating in the TDM Market are F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), and Abbott (US).
The scope of the study includes the various consumables and equipment’s used to perform therapeutic drug monitoring assays What the Market Looks Like?
Predicted to grow at a CAGR of 5.9% during the forecast period, the Global Therapeutic Drug Monitoring Market is estimated to reach USD 1.63 billion by the end of 2023.
Asia Pacific is expected to grow at the highest CAGR during the forecast period Based on product, the global market is segmented into consumables and equipment.
This growth can be attributed to the requirement of repeat purchase of kits and reagents, coupled with the increasing number of immunoassay tests being performed across the globe as a result of the rising incidence of chronic and infectious diseases.
The immunoassays segment is expected to account for the largest share of this market in 2018, mainly due to the increasing incidence of chronic and infectious diseases and technological innovation.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443 What Drives the Market?
Anticoagulant Therapeutic Drug Monitoring Assay Kits market is segmented by companies, region (country), by Type, and by Application.
Players, stakeholders, and other participants in the global Anticoagulant Therapeutic Drug Monitoring Assay Kits market will be able to gain the upper hand as they use the report as a powerful resource.
The segmental analysis focuses on market size and forecast for the period 2016-2027.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-anticoagulant-therapeutic-drug-monitoring-assay-kits-key-trends-opportunities-2027-629Segment by Type, the Anticoagulant Therapeutic Drug Monitoring Assay Kits market is segmented into High Performance Liquid ChromatographyFluorescence Polarization ImmunoassayEnzyme-linked Immunosorbent AssayRadioimmunoassay, Homogenous Enzyme Immunoassay, etc.Segment by Application, the Anticoagulant Therapeutic Drug Monitoring Assay Kits market is segmented intoHospitalsIntensive Care UnitsSurgical CentersSpecialty ClinicsRegional and Country-level AnalysisThe report offers exhaustive assessment of different region-wise and country-wise Anticoagulant Therapeutic Drug Monitoring Assay Kits markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players forNorth AmericaEuropeAsia-PacificLatin AmericaMiddle East & Africa.Competitive Landscape and Anticoagulant Therapeutic Drug Monitoring Assay Kits Market Share AnalysisAnticoagulant Therapeutic Drug Monitoring Assay Kits market competitive landscape provides details and data information by vendors.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021.
It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021.
Therapeutic Drug Monitoring (TDM) Market - OutlineThe pandemic situation caused by the outbreak of novel coronavirus is expected to increase the demand for products and services in the global therapeutic drug monitoring (TDM) market in coming years.
Players and manufacturers in the global therapeutic drug monitoring (TDM) market are providing various equipment and management tools such as calibrators and controls to aid the pharmaceutical and clinical research laboratories in new drug discovery processes.
Rising number of people requiring round the clock care, increasing number of patients being admitted to healthcare facilities, and substantial rise in the testing volumes are also propelling growth in the global therapeutic drug monitoring (TDM) market.
This trend is attributed to the significance of TDM equipment in the organ transplant procedures.Request COVID Analysis on Therapeutic Drug Monitoring Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=39239 Therapeutic drug monitoring (TDM) is the clinical practice of determining the concentration of a specific drug in a patient’s bloodstream at different intervals.
Therapeutic drug monitoring (TDM) helps to sustain a constant volume of drug in bloodstream required to show therapeutic effects without toxic effects, thereby optimizing individual dosage regimens.
TDM serves in assessing the efficiency and safety of a medication when administered into the individual patient.Request Customization on Therapeutic Drug Monitoring Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=39239 The therapeutic drug monitoring (TDM) market is anticipated to witness healthy growth during the forecast period, owing to steep rise in the demand for better healthcare for the growing urban population.
